Henry Schein Inc. (HSIC)
NASDAQ: HSICHealth CareMedical SpecialitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
HSIC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $9.32B
- P/E (TTM)
- 24.39
- Forward P/E
- 13.98
- EPS (TTM)
- $3.43
- Dividend yield
- None
- 52-week range
- 61.95 – 92.18
- Day range
- 83.57 – 85.64
- Volume / Avg
- 1.31M / 1.20M
- Beta
- —
- Shares outstanding
- 111.45M
- Next earnings
- Nov 3, 2026
52-week range
HSIC stock today
Henry Schein (HSIC) closed at $83.66 on Oct 7, down 1.39% (-$1.18), versus the S&P 500's 0.22% decline. Shares are 9.2% below their 52-week high of $92.18, set on Aug 4, 2026 and 35.0% above the 52-week low of $61.95, in the middle of the past year's range. HSIC is up 10.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 28.9%.
At 24.4x trailing earnings, Henry Schein trades in line with the peer-group median of 25.5x. Its forward P/E of 14.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Henry Schein's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Henry Schein
Company profileHenry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Andrea Albertini
- Headquarters
- Melville, NY
- Employees
- 25,000
- IPO year
- 1995
- Website
- henryschein.com
Financial highlights
Full financialsIn fiscal 2025, Henry Schein generated $13.18 billion in revenue, up 4.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $398.0 million (+2.1% year over year), for a net margin of 3.0% versus a median of 4.0% in the prior 5 years. Gross margin was 31.1% (down from 31.7%) and operating margin 5.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Growth | +4.03% | +2.71% | -2.44% | +1.98% | +22.55% |
| Net income | $398.00M | $390.00M | $416.00M | $538.00M | $631.00M |
| EPS (diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
Analyst forecast
ForecastConsensus (16 analysts)
buy
Avg. price target
$97.27+16.27%
- Strong buy 4
- Buy 4
- Hold 7
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $1.34
- Last reported (Q2 2026)
- Aug 4, 2026
- EPS actual vs est.
- $0.82 vs —
Henry Schein peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OSCROscar Health Inc. Class A | 32.91 | +1.76% | $10.16B | vs HSIC |
| MOHMolina Healthcare Inc | 194.82 | -0.18% | $10.17B | vs HSIC |
| CAICaris Life Sciences Inc. | 27.10 | -1.29% | $7.66B | vs HSIC |
| GRALGRAIL Inc. | 132.90 | -3.19% | $5.94B | vs HSIC |
| RDNTRadNet Inc. | 68.61 | -2.38% | $5.40B | vs HSIC |
| CONConcentra Group Holdings Parent Inc. | 36.40 | 0.00% | $4.64B | vs HSIC |
| BLLNBillionToOne Inc. Class A | 95.75 | -4.19% | $4.52B | vs HSIC |
| VCYTVeracyte Inc. | 43.16 | -3.34% | $3.47B | vs HSIC |
Indexes, lists and sector
Index membership
Henry Schein stock FAQ
What is Henry Schein's stock price today?
HSIC last traded at $83.66 as of Oct 7, 4:00 PM EDT, down 1.39% on the day. Prices are delayed at least 15 minutes.
Does Henry Schein pay a dividend?
No. Henry Schein does not currently pay a regular cash dividend.
When is Henry Schein's next earnings date?
Henry Schein is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $1.34.
What is HSIC's P/E ratio?
HSIC trades at a trailing P/E ratio of 24.39 and a forward P/E of 13.98, compared with a median of 25.5 for its closest peers.
Is Henry Schein in the S&P 500?
Yes. Henry Schein (HSIC) is a constituent of the S&P 500 index.
Who is Henry Schein's CEO?
Mr. Andrea Albertini is the chief executive officer of Henry Schein Inc., which has about 25,000 employees.
Has HSIC ever split its stock?
Yes. The most recent HSIC stock split was a 1275-for-1000 split on Feb 8, 2019, one of 3 splits on record.